MLL3 is a de novo cause of endocrine therapy resistance is a research paper published in Cancer Medicine (2021). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: K08 CA148912
National Institutes of Health
Grant: 1K08CA148912-01A1
High-throughput Analysis of Mutations Identified by RNA-sequencing Triple Negativ
FWCI
0.85
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals